ASN Press Releases

AMERICAN SOCIETY OF NEPHROLOGY AND THE U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES LAUNCH $4M KIDNEYX EMPOWER PRIZE CHALLENGE TO BOOST LIVING KIDNEY DONATION

Wed, 15 Apr 2026 15:00:00 GMT

The American Society of Nephrology (ASN) in collaboration with the U.S. Department of Health and Human Services (HHS), is launching the 2026 KidneyX EMPOWER Prize Challenge, a new $4 million national prize competition to accelerate innovation in support of living kidney donors and the people with kidney diseases whose lives depend on them. The competition, slated to open on April 15, invites submissions from a wide range of participants, including patients, living donors, caregivers, health care professionals, researchers, technology and digital health companies, engineers, and entrepreneurs.

AMERICAN SOCIETY OF NEPHROLOGY HEALTH POLICY SCHOLAR PROVIDES TESTIMONY AT HOUSE COMMITTEE HEARING ON IMPROVING KIDNEY HEALTH THROUGH BETTER PREVENTION AND INNOVATIVE TREATMENT

Wed, 18 Mar 2026 21:01:00 GMT

Today, the American Society of Nephrology (ASN) testified before the House Committee on Ways and Means Subcommittee on Health hearing on Improving Kidney Health through Better Prevention and Innovative Treatment.

AMERICAN SOCIETY OF NEPHROLOGY OFFERS NEW KIDNEY HEALTH GUIDANCE ON CONSERVATIVE MANAGEMENT IN PEOPLE WITH KIDNEY FAILURE

Wed, 18 Mar 2026 17:00:00 GMT

The American Society of Nephrology (ASN) today released its latest Kidney Health Guidance (KHG): Conservative Management in People with Kidney Failure, in the Journal of the American Society of Nephrology (JASN). The new KHG, and companion Executive Summary, provides evidence-based support for the core components of the conservative management care pathway, including customized CKD care to align with a person's values and goals, symptom management, and navigation of care transitions through the end of life.

AMERICAN SOCIETY OF NEPHROLOGY CALLS ON CONGRESS TO ADVANCE CRITICAL KIDNEY HEALTH RESEARCH AND SUPPORT LIVING DONORS

Tue, 10 Mar 2026 12:30:00 GMT

Today, leaders from the American Society of Nephrology (ASN) are meeting with their congressional delegations to urge bipartisan support for critical kidney health priorities that can accelerate research, transform care, expand access to transplantation, and strengthen support for living donors.

AMERICAN SOCIETY OF NEPHROLOGY CELEBRATES NEW LEGISLATION TO EXPAND SUPPORT FOR LIVING DONORS

Mon, 09 Mar 2026 20:00:00 GMT

The American Society of Nephrology (ASN) celebrates the introduction of the Expanding Support for Living Donors Act of 2026, legislation that would bolster and expand support for living organ donors.

AMERICAN SOCIETY OF NEPHROLOGY VOICES SUPPORT FOR STATUTE GALVANIZING ADDITIONAL PROTECTIONS FOR LIVING DONORS

Wed, 25 Feb 2026 21:30:00 GMT

The American Society of Nephrology (ASN) applauds the forthcoming markup of the Living Donor Protection Act of 2025 by the Senate Committee on Health, Labor, Education, and Pensions (HELP) on Thursday, February 26, 2026. This legislation aims to eliminate known barriers to living donation—the optimal form of therapy for most people with kidney failure—by galvanizing key protections in statute.

AMERICAN SOCIETY OF NEPHROLOGY COMMENDS KIDNEY HEALTH CHAMPIONS UPON ENACTMENT OF THE HONOR OUR LIVING DONORS (HOLD) ACT

Wed, 04 Feb 2026 18:06:00 GMT

The American Society of Nephrology (ASN) commends Senator John Boozman (R-AR), Representative Suzan DelBene (D-WA), Senator Ben Ray Luján (D-NM), and Representative Jay Obernolte (R-CA) for their leadership enacting the Honor Our Living Donors (HOLD) Act on February 3, 2026—legislation that will improve financial support for living donors.

SAMIR M. PARIKH, MD, FASN, NAMED PRESIDENT OF THE AMERICAN SOCIETY OF NEPHROLOGY

Thu, 01 Jan 2026 14:00:00 GMT

The American Society of Nephrology (ASN) today announced that Samir M. Parikh, MD, FASN has become the society's president on January 1, 2026. Dr. Parikh succeeds Dr. Prabir Roy-Chaudhury who led ASN in 2025

$3 MILLION DONATION FROM THE VERTEX FOUNDATION ESTABLISHES A NEW AMERICAN SOCIETY OF NEPHROLOGY INITIATIVE: EXCELLENCE IN KIDNEY CARE IMMUNOLOGY, TRAINING, AND EDUCATION

Wed, 12 Nov 2025 20:05:00 GMT

• The Vertex Foundation has committed to contributing $3 million to the American Society of Nephrology (ASN) to establish Excellence in Kidney Care Immunology, Training, and Education (EKCITE). • This program will train the kidney workforce in the implementation of the new immune-mediated therapies across a spectrum of kidney diseases.

Quality Improvement Intervention May Help Prevent Deaths from Metformin-Associated Lactic Acid

Sat, 08 Nov 2025 22:30:00 GMT

• A diagnosis and treatment protocol including the prompt initiation of dialysis led to reduced mortality from metformin-associated lactic acidosis at a hospital in Thailand. • The findings will be presented at American Society of Nephrology (ASN) Kidney Week 2025 November 5–9.

Conservative Care Versus Dialysis: Model Indicates Which Is Best for Individual Patients with Advanced Chronic Kidney Disease

Sat, 08 Nov 2025 22:30:00 GMT

• Researchers developed and validated a model that estimates individualized survival probabilities with conservative management versus dialysis in patients with advanced chronic kidney disease. • The findings will be presented at American Society of Nephrology (ASN) Kidney Week 2025 November 5–9.

Transitional Dialysis Program in Texas Decreased the Use of Emergency Dialysis

Sat, 08 Nov 2025 22:30:00 GMT

• A transitional dialysis program piloted in Austin, TX lowered the use of costly emergency dialysis in uninsured people with kidney failure, and it facilitated permanent dialysis access placement and transplant evaluations. • The findings will be presented at American Society of Nephrology (ASN) Kidney Week 2025 November 5–9.

Study Reveals a Potentially Better Way to Optimize the Timing for Kidney Transplant Waitlisting

Sat, 08 Nov 2025 22:30:00 GMT

• Expanding the waitlisting criteria for kidney transplantation to include risk of kidney failure—rather than taking a single measurement of kidney function—could improve outcomes in younger patients and reduce racial disparities in access to kidney transplantation. • The findings will be presented at American Society of Nephrology (ASN) Kidney Week 2025 November 5–9.

Study Reports on Global Trends in Acute Kidney Injury–Related Mortality

Sat, 08 Nov 2025 22:30:00 GMT

• A global analysis indicates that countries with higher socioeconomic status and older populations are experiencing increasing rates of acute kidney injury–related mortality, a trend projected to continue through 2050. • The findings will be presented at American Society of Nephrology (ASN) Kidney Week 2025 November 5–9.

High-Impact Clinical Trials Generate Promising Results for Improving Kidney Health

Sat, 08 Nov 2025 16:30:00 GMT

The results of numerous high-impact phase 3 clinical trials that could affect kidney-related medical care will be presented in-person at the American Society of Nephrology Kidney Week 2025 November 5–9.

Sotagliflozin Outperforms Dapagliflozin for Reducing Salt-Sensitive Hypertension and Kidney Injury in Rats

Fri, 07 Nov 2025 22:30:00 GMT

• Dual inhibition of sodium-glucose co-transporters 1 and 2 with the recently approved drug sotagliflozin may be an especially effective treatment for salt-sensitive hypertension. • The findings will be presented at American Society of Nephrology (ASN) Kidney Week 2025 November 5–9.

Study Uncovers Glomerular Disease Outcomes Across the Lifespan

Fri, 07 Nov 2025 22:30:00 GMT

• A recent analysis of 2,915 patients with primary glomerular diseases indicates that young patients may face similar risks of kidney function decline as older patients, indicating that they are more likely to need dialysis or a kidney transplant during their lifetimes. • The findings will be presented at American Society of Nephrology (ASN) Kidney Week 2025 November 5–9.

Trial Analysis Reveals Almost All Adults with Hypertensive Chronic Kidney Disease Would Benefit from Intensive Blood Pressure Lowering

Fri, 07 Nov 2025 22:30:00 GMT

• Nearly all SPRINT participants with hypertension and nondiabetic chronic kidney disease stages 3–4 had a net benefit (the predicted difference between benefits and harms) that favored a systolic blood pressure target of <120 mm Hg compared with <140 mm Hg. • The findings will be presented at American Society of Nephrology (ASN Kidney Week 2025 November 5–9.

High-Impact Clinical Trials Generate Promising Results for Improving Kidney Health

Fri, 07 Nov 2025 16:30:00 GMT

Houston, TX (November 7, 2025) — The results of numerous high-impact phase 3 clinical trials that could affect kidney-related medical care will be presented in-person at ASN Kidney Week 2025 November 5–9.

High-Impact Clinical Trials Generate Promising Results for Improving Kidney Health

Thu, 06 Nov 2025 14:50:00 GMT

Houston, TX (November 6, 2025) — The results of high-impact phase 3 clinical trials that could affect kidney-related medical care will be presented in-person at ASN Kidney Week 2025 November 5–9.